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Introduction
At the end of mitosis, after chromosome segregation, eukaryotic 
cells must inactivate the cyclin B–dependent kinases that lead 
them into and through mitosis. This inactivation is necessary for 
spindle disassembly, cytokinesis, and entry into a new round of 
DNA replication in the subsequent cell cycle. Critical to this 
process is cyclin B proteolysis triggered by the anaphase-
  promoting complex/cyclosome (Peters, 2002). Inactivation of 
mitotic Cdks in budding yeast is driven by activation of a com-
plex signal transduction cascade, called the mitotic exit network 
(MEN), which is required for mitotic exit and cytokinesis. The 
MEN comprises several factors, including a small G protein of 
the Ras family (Tem1), its activator (Lte1), several protein ki-
nases and associated factors (namely Cdc5, Cdc15, Mob1/Dbf2, 
Dbf20, and Cla4), and a scaffold protein (Nud1). The latter acts 
as a platform for many MEN components at the microtubule 
  organizing center or spindle pole body (SPB; Simanis, 2003; 
Seshan and Amon, 2004). A similarly organized pathway, the 
septation initiation network, drives cytokinesis in fi  ssion yeast 
(Simanis, 2003), and homologues of several MEN and septation 
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initiation network factors can be found in multicellular eukary-
otes. The ultimate effector of MEN signaling is the Cdc14 pro-
tein phosphatase, which on one side can directly reverse Cdk 
phosphorylation events (Gray et al., 2003) and on the other pro-
motes inactivation of cyclin B–dependent kinases by triggering 
anaphase-promoting complex/cyclosome–dependent cyclin 
proteolysis and accumulation of their specifi  c inhibitor Sic1 
(for review see Stegmeier and Amon, 2004). Though completed 
by the MEN in telophase, Cdc14 activation is already initiated 
during anaphase by the action of the Cdc14 early anaphase 
  release (FEAR) pathway, which includes the polo kinase Cdc5 
and the separase Esp1 (Stegmeier et al., 2002).
To ensure balanced chromosome partitioning, inactivation 
of mitotic Cdks must not be initiated before telophase, i.e., be-
fore sister chromatid segregation is complete. This issue is vital 
for organisms like budding yeast, which defi  ne the cleavage 
plane early in the cell cycle and before bipolar spindle forma-
tion. In fact, in Saccharomyces cerevisiae, the constriction be-
tween mother and daughter cells (bud neck) appears at the G1–S 
transition concomitantly with bud emergence and dictates where 
cytokinesis will later take place. The spindle positioning check-
point is responsible for delaying cytokinesis until the spindle 
enters the bud. The Bub2/Bfa1 GTPase-activating protein 
(GAP) plays a key role in this process by keeping Tem1 inactive 
until the spindle is properly oriented, thus inhibiting MEN 
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B
udding yeast spindle position checkpoint is engaged 
by misoriented spindles and prevents mitotic exit by 
inhibiting the G protein Tem1 through the GTPase-
activating protein (GAP) Bub2/Bfa1. Bub2 and Bfa1 are 
found on both duplicated spindle pole bodies until ana-
phase onset, when they disappear from the mother-bound 
spindle pole under unperturbed conditions. In contrast, 
when spindles are misoriented they remain symmetrically 
localized at both SPBs. Thus, symmetric localization of 
Bub2/Bfa1 might lead to inhibition of Tem1, which is also 
present at SPBs. Consistent with this hypothesis, we show 
that a Bub2 version symmetrically localized on both SPBs 
throughout the cell cycle prevents mitotic exit in mutant 
backgrounds that partially impair it. This effect is Bfa1 
dependent and can be suppressed by high Tem1 levels. 
Bub2 removal from the mother-bound SPB requires its 
GAP activity, which in contrast appears to be dispensable 
for Tem1 inhibition. Moreover, it correlates with the pas-
sage of one spindle pole through the bud neck because it 
needs septin ring formation and bud neck kinases.T
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  activation (for review see Stegmeier and Amon, 2004). 
Bub2/Bfa1 is found on both SPBs soon after SPB duplication 
but only on the SPB directed into the bud, along with Tem1, 
from the onset of anaphase until the end of mitosis. This obser-
vation, along with the fi  nding that the Tem1 activator Lte1 is lo-
calized specifi  cally in the bud, led to the proposition that MEN 
activation is triggered by an encounter between Tem1 sitting on 
the bud-directed SPB and Lte1, thus coupling properly oriented 
spindle elongation with mitotic exit (Bardin et al., 2000; Pereira 
et al., 2000). However, Lte1 is required for mitotic exit only at 
low temperatures (Shirayama et al., 1994) and is dispensable 
for inappropriate mitotic exit of mutants with spindle position-
ing defects (Adames et al., 2001). Thus, other mechanisms, 
such as inactivation of the GAP Bub2/Bfa1, must ensure the 
timely activation of Tem1. Inhibitory phosphorylation of Bfa1 
by the Polo kinase Cdc5, although not essential, clearly contrib-
utes to this task (Hu et al., 2001). Unlike Bub2/Bfa1, Tem1 is 
also present on the mother-bound SPB from the time of bipolar 
spindle formation to telophase. This suggests that disappear-
ance of Bub2/Bfa1 from that SPB at the onset of anaphase might 
be important for proper MEN activation. In agreement with this 
hypothesis, activation of the spindle position checkpoint by ei-
ther microtubule depolymerization or mutations impairing spin-
dle orientation preserves Bub2/Bfa1 on both SPBs (Pereira 
et al., 2001; Molk et al., 2004).
In this paper, we investigate the role of Bub2/Bfa1 local-
ization at SPBs in controlling mitotic exit. Our data indicate that 
Bub2/Bfa1 disappearance from the mother-bound SPB at the 
onset of anaphase, along with Cdc5 function, helps prompt 
Tem1 activation in telophase. This asymmetric disappearance 
of Bub2/Bfa1 requires Bub2 GAP activity and depends on a 
functional septin ring, consistent with the notion that passage of 
the daughter-oriented SPB through the bud neck signals mitotic 
exit (Molk et al., 2004). Altogether, our data highlight a new 
molecular mechanism coupling MEN activation with passage 
of the nucleus through the bud neck.
Results
Symmetrically localized Bub2-myc9 is lethal 
to some MEN-defective mutants
Because activation of the spindle position checkpoint leads to 
the persistence of Bub2/Bfa1 on both SPBs (Pereira et al., 2001; 
Molk et al., 2004), symmetric distribution of the GAP could 
contribute to keeping Tem1 inactive. In fact, Tem1 is also pre-
sent on both SPBs during unperturbed anaphase (Molk et al., 
2004). We therefore asked whether Bub2’s disappearance from 
the SPB remaining in the mother cell could be important for 
proper mitotic exit.
We previously showed that a modifi  ed version of Bub2 
with nine myc epitopes at the COOH terminus (Bub2-myc9) 
  localizes symmetrically on both SPBs throughout the cell cycle 
(Fraschini et al., 1999), unlike the GFP-tagged counterpart 
(Pereira et al., 2000). This difference was attributed to the assay 
we used at that time (Pereira et al., 2000), which relied on a 
chromosome-spreading technique. We therefore reinvestigated 
Bub2 subcellular localization by indirect immunofl  uorescence 
on fi  xed cells of strains expressing either Bub2-myc9 or the 
Bub2-HA3 and Bub2-HA6 variants, carrying three and six HA 
epitopes, respectively, at the COOH terminus. We found that 
Bub2-HA3 (Fig. 1 A) localized asymmetrically on the SPB 
moving into the bud in 93% (±1.3%, n = 289) of the cells un-
dergoing anaphase, similar to Bub2-HA6 (not depicted), 
whereas Bub2-myc9 was present on both SPBs in 88.3% (±7.9, 
n = 408) of the cells in the same stage of the cell cycle (Fig. 1 B). 
Therefore, symmetric localization is a peculiarity of Bub2-myc9, 
Figure 1.  Effects of symmetrically localized 
myc-tagged Bub2 on Bfa1 and Tem1 localiza-
tion and cdc5-2 cell viability.  (A) Exponen-
tially growing cells expressing Bub2-HA3 
(ySP3866), Bfa1-HA6 (ySP2035), or Tem1-
HA3 (ySP3641) were stained by indirect im-
munoﬂ  uorescence with anti-HA antibodies and 
mounted with DAPI to stain DNA. (B) Cells 
expressing Bub2-myc9 alone (ySP710) or in 
combination with Bfa1-HA6 (ySP5087) or 
Tem1-HA3 (ySP4625) were treated as in A, 
  using anti-myc antibodies to detect Bub2-myc9. 
Only anaphase cells were photographed. The 
arrows point to the bud. (C) Serial dilutions of 
logarithmically growing cultures of wild-type 
(ySP41),  BUB2-myc9 (ySP710), MET3-CDC5 
cdc5-2 (ySP3426), and MET3-CDC5 cdc5-2 
BUB2-myc9 (ySP3442) cells, either untrans-
formed or carrying one extra copy of BUB2 
integrated at the URA3 locus (MET3-CDC5 
cdc5-2 BUB2-myc9 BUB2 a and b, ySP3743, 
and ySP3744), were spotted on –Met (MET3 
promoter on) or +Met (MET3 promoter off) 
plates and incubated for 2 d at 25°C.T
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rather than an artifact attributable to the immunostaining 
 procedure. Because Bub2 forms a complex with Bfa1 and  either 
protein is necessary for proper localization of the other at 
SPBs (Pereira et al., 2000), we analyzed the localization of a 
fully functional Bfa1 variant tagged with six HA epitopes (Bfa1-
HA6) in cells expressing Bub2-myc9 as the only Bub2 source. 
As previously shown (Pereira et al., 2000), Bfa1-HA6 was 
asymmetrically localized on the bud-directed SPB in 91.8% 
(±4.1%,  n  = 319) of wild-type anaphase cells (Fig. 1 A), 
whereas it was found on both SPBs in 58.2% (±10.6%, n = 446) 
of  BUB2-myc9 anaphase cells (Fig. 1 B), indicating that 
Bub2-myc9’s persistence on the mother cell SPB prevents 
Bfa1’s disappearance from the same SPB in many anaphase 
cells (Fig. 1 B). Similarly, a Tem1-HA3–tagged protein was 
found symmetrically localized on both SPBs in 83.8% (±0.8%, 
n = 251) of anaphase cells expressing Bub2-myc9 (Fig. 1 B), 
whereas it was present on both SPBs in only 27.2% (±1.0%, 
n = 174) of wild-type anaphase cells (Fig. 1 A).
Symmetric localization of Bub2/Bfa1 did not cause any 
obvious cell cycle defect in otherwise wild-type cells (unpub-
lished data). However, because Tem1 activation is likely regu-
lated by redundant mechanisms, we looked for synthetic 
effects between Bub2-myc9 and mutations affecting the MEN. 
As shown in Table I, although Bub2-myc9 was perfectly toler-
ated by mutants defective in MEN proteins acting downstream 
of Tem1, such as cdc15-2, dbf2-2, and cdc14-3, it was lethal 
at the permissive temperature for tem1-3, nud1-44,  cdc5-1, 
cdc5-2, and cdc5-3 mutants, suggesting that its presence is toxic 
when Tem1 activation is impaired. In fact, Nud1 is thought to 
act as an anchor for Tem1 and other MEN components at SPBs, 
whereas Cdc5 promotes Tem1 activation at different levels 
(Simanis, 2003; Stegmeier and Amon, 2004). Surprisingly, 
BUB2-myc9 was not toxic for lte1∆ cells, presumably because 
Lte1 is dispensable for mitotic exit at 25°C (Shirayama et al., 1994; 
Bardin et al., 2000; Pereira et al., 2000; Hofken and Schiebel, 
2002; Seshan et al., 2002; Yoshida et al., 2003), whereas it 
caused a synthetic growth defect to cla4∆ cells that are defec-
tive in mitotic exit and in Lte1 activation (Hofken and Schiebel, 
2002; Seshan et al., 2002; Chiroli et al., 2003). Noticeably, 
 deletion  of  BUB2 was not lethal for any of the aforementioned 
mutants, indicating that the synthetic lethality of BUB2-myc9 
with the tem1, cdc5, and nud1 conditional alleles is not attribut-
able to BUB2’s loss of function. Accordingly, unlike BUB2 
 deletion,  expression  of  BUB2-myc9 as the only Bub2 source in 
the cells did not impair checkpoint activation (Fraschini et al., 
1999) and did not cause lethality to cells lacking the kinesin 
Cin8 (Table I). Moreover, the BUB2-HA3 allele, whose product 
localizes asymmetrically on SPBs during anaphase, was per-
fectly tolerated by tem1, nud1, and cdc5 mutants (Table I). 
Thus, Bub2-myc9 behaves like a gain-of-function variant down-
regulating Tem1, and its deleterious effects might be linked to 
symmetric SPB localization of Bub2/Bfa1.
BUB2-myc9 is a dominant allele causing 
Bfa1-dependent mitotic exit defects 
in cdc5-2 cells
To uncover the defects caused by Bub2-myc9 in MEN mutants, 
we chose to make a conditionally lethal cdc5-2 BUB2-myc9 
strain. Because Cdc5 is an unstable protein, we generated a 
cdc5-2 BUB2-myc9 strain carrying a wild-type copy of CDC5 
under the control of the Met-repressible MET3 promoter. As 
shown in Fig. 1 C, MET3-CDC5 cdc5-2 BUB2-myc9 cells were 
viable in medium lacking Met, where MET3-CDC5 is expressed, 
but they were unviable in Met-containing medium at 25°C (per-
missive temperature for cdc5-2). This behavior did not change 
when one extra copy of BUB2 was integrated into the genome 
of BUB2-myc9 cdc5-2 MET3-CDC5 cells (Fig. 1 C), indicating 
that BUB2-myc9 is a dominant allele.
To analyze the terminal phenotype caused by the BUB2-
myc9 cdc5-2 combination, cell cultures of wild-type, cdc5-2 
MET3-CDC5, and BUB2-myc9 cdc5-2 MET3-CDC5 strains, 
  exponentially growing in the absence of Met, were synchro-
nized in G1 with α factor and released at 25°C into fresh 
medium containing Met to shut off CDC5 expression. 
The pheromone was added back 120 min after release to prevent 
cells from entering a second cell cycle. FACS profi  les of DNA 
contents (Fig. 2 A) and analysis of nuclear division and spindle 
elongation (Fig. 2 B) showed that cdc5-2 cells progressed nor-
mally through the cell cycle with kinetics similar to wild-type 
cells. Conversely, BUB2-myc9 cdc5-2 cells accumulated with 
2C DNA content, two divided nuclei, and long anaphase spin-
dles. In addition, unlike cdc5-2 cells, they failed to bring about 
Clb2 proteolysis, Sic1 reaccumulation, and inactivation of the 
Clb2/Cdk1 kinase (Fig. 2 C), indicating that mitotic exit was 
compromised. In some experiments, spindles could eventually 
disassemble at 210–240 min after release from the G1 arrest, 
although cells could neither undergo cytokinesis nor rebud 
and re-replicate. Overexpression of BUB2 from the galactose-
 inducible  GAL1 promoter had similar effects in cdc5-2 cells 
as the presence of Bub2-myc9. In fact, cdc5-2 cells express-
ing GAL1-BUB2 were unviable in galactose-containing medium 
Table I. Genetic interactions between BUB2 alleles and mutations 
affecting the MEN
Strain bub2𝖫 BUB2-HA3 BUB2-myc9
cin8∆  −+ +
cdc5-1 ++ −
cdc5-2 ++ −
cdc5-3  ++ −
tem1-3  ++ −
nud1-44  ++ −
cdc14-3  + ND +
cdc15-2  + ND +
dbf2-2  + ND +
lte1∆  + ND +
cla4∆  + ND +/−
BFA1-11A ND ND +
Strains carrying the BUB2 alleles indicated in the ﬁ  rst row were crossed with a 
cin8∆ strain as a control of checkpoint proﬁ  ciency and with the MEN-defective 
mutants listed in the left column, followed by sporulation and tetrad dissection 
on YEPD. At least 12 tetrads were analysed for each cross. + indicates the abil-
ity to form normal-sized colonies, − indicates no growth, and +/− indicates a 
synthetic growth effect of segregants carrying the indicated allele combinations 
after 3 d at 25°C. In all cases, the frequency of double mutants was that ex-
pected from the segregation of two unlinked markers (25%), and the indicated 
phenotypes were 100% penetrant.JCB • VOLUME 172 • NUMBER 3 • 2006  338
at the permissive temperature and accumulated in telophase 
with 2C DNA content, two divided nuclei, and long anaphase 
spindles (Fig. S1, available at http://www.jcb.org/cgi/content/
full/jcb.200507162/DC1), whereas overexpression of the same 
construct in wild-type cells caused no growth defect and at most 
a 15-min delay in mitotic exit compared with the isogenic un-
transformed strain. Thus, high levels of wild-type Bub2 recapit-
ulate the effects of Bub2-myc9 in cdc5-2 cells, consistent with 
the notion that BUB2-myc9 is a gain-of-function allele.
Because Bub2 acts in a complex with Bfa1, which is re-
quired for Bub2 localization at SPBs (Pereira et al., 2000), dele-
tion of BFA1 could be expected to bypass the mitotic exit delay 
of  BUB2-myc9 cdc5-2 cells. Indeed, MET3-CDC5 cdc5-2 
BUB2-myc9 bfa1∆ cells released from a G1 block in the pres-
ence of Met could exit mitosis, disassemble spindles, and reac-
cumulate mononucleate cells with kinetics similar to those of 
MET3-CDC5 cdc5-2 cells under the same conditions (Fig. 3), 
indicating that Bfa1 is required for Bub2-myc9 to exert its 
  inhibitory function on mitotic exit in cdc5-2 cells.
Whereas the MEN is absolutely required for Cdc14 acti-
vation, mutants defective in the FEAR pathway only delay 
 mitotic exit (for review see Stegmeier and Amon, 2004). We there -
fore asked whether Bub2-myc9 could further compromise mi-
totic exit in separase esp1-1 mutant cells at the nonpermissive 
temperature. Separase inactivation at 37°C prevents sister 
  chromatid separation (Ciosk et al., 1998) and mildly delays mi-
totic exit, allowing the undivided nuclei to enter a new round of 
DNA replication and accumulate with DNA contents higher 
than 2C (Cohen-Fix and Koshland, 1999; Tinker-Kulberg and 
Morgan, 1999; Stegmeier et al., 2002; Sullivan and Uhlmann, 
2003).   Expression of Bub2-HA6, which was asymmetrically 
localized on SPBs, did not affect cell cycle progression of esp1-1 
cells (Fig. S2, available at http://www.jcb.org/cgi/content/full/
jcb.200507162/DC1). Conversely, expression of Bub2-myc9, 
which was present on both SPBs in most esp1-1 cells, prevented 
them from undergoing mitotic exit and entry into a new round 
of DNA replication (Fig. S2). Thus, the constitutive presence of 
Bub2/Bfa1 at both SPBs might inhibit mitotic exit when the 
FEAR pathway is compromised by separase inactivation. In ad-
dition, because the mitotic exit of esp1-1 cells has been attrib-
uted to the peculiar migration of the undivided nuclei and 
embedded SPBs into the bud (McGrew et al., 1992), which 
would lead to Tem1 exposure to Lte1 (Bardin et al., 2000), our 
data argue that the encounter between Lte1 and Tem1 in the bud 
is not suffi  cient to promote mitotic exit when Bub2-myc9 is 
present in the cells, and therefore the Bub2–Bfa1 complex is 
symmetrically localized on SPBs.
MEN hyperactivation can rescue 
the inhibitory effects of Bub2-myc9
Because expression of Bub2-myc9 prevented mitotic exit when 
either the MEN or the FEAR pathway was partially impaired, 
we directly tested to determine whether MEN hyperactivation 
by different means could bypass the mitotic exit defect of 
BUB2-myc9 cdc5-2 cells. As shown in Fig. 4 A, high levels of 
the Tem1 activator Lte1 can counteract the deleterious effects 
of Bub2-myc9 because galactose induction of a GAL1-LTE1 fu-
sion could suppress the BUB2-myc9 cdc5-2 synthetic lethality, 
tipping the balance in favor of Tem1 activation. In addition, the 
CDC14
TAB6-1 allele (Shou et al., 2001), encoding a constitutively 
active variant of the downstream MEN target, restored viability 
of BUB2-myc9 cdc5-2 cells (Fig. 4 B), consistent with their fail-
ure to activate the MEN. Conversely, deletion of either AMN1 
or DMA1 and DMA2, whose gene products counteract MEN 
activation (Wang et al., 2003; Fraschini et al., 2004), did not 
suppress BUB2-myc9 cdc5-2 (unpublished data). Remarkably, 
Figure 2.  Expression of Bub2-myc9 delays 
mitotic exit in cdc5-2 cells at permissive 
  temperature.  Cultures of wild-type (ySP41), 
MET3-CDC5 cdc5-2 (ySP3426), and MET3-
CDC5 cdc5-2 BUB2-myc9 cells (ySP3480), 
  exponentially growing in –Met medium, were 
arrested in G1 with α factor and released at 
25°C in YEPD supplemented with 2 mM Met 
(MET3-CDC5 expression off). After 120 min, 
10 μg/ml α factor was readded to prevent 
cells from entering a second cell cycle. Cells 
were collected at the indicated times for FACS 
analysis of DNA contents (A); kinetics of bud-
ding, nuclear division, and spindle elonga-
tion/breakdown after in situ immunostaining 
of tubulin (B); and Western analysis of Clb2 
and Sic1, as well as Clb2/Cdk1 immunopre-
cipitations followed by kinase assays using his-
tone H1 as substrate (C). Swi6 was used as 
loading control.BUB2 LOCALIZATION AND MITOTIC EXIT CONTROL • FRASCHINI ET AL. 339
TEM1 suppressed the lethal effects of the BUB2-myc9 cdc5-2 
combination not only when expressed from either the GAL1 
promoter or from its attenuated version GALs (Fig. 4 A) but 
even when just one extra copy was expressed from its own pro-
moter, suggesting that Tem1 becomes limiting in cdc5-2 BUB2-
myc9 strains (Fig. 4 A). It is important to notice that overexpressed 
Tem1 did not disrupt the symmetric localization of Bub2-myc9 
(unpublished data), suggesting that suppression is not attribut-
able to Bub2 titration from SPBs.
Bub2 GAP activity is not required 
to inhibit Tem1 but promotes Bub2/Bfa1 
disappearance from the mother-bound SPB
We investigated whether the toxic effects of Bub2-myc9 on 
  mitotic exit were attributable to increased GAP activity on 
Tem1 by using bacterially expressed and purifi  ed 6×His-Tem1, 
maltose binding protein (MBP)–Bfa1, and GST-Bub2 fusions in a 
previously described in vitro GAP assay (Geymonat et al., 2002). 
The rate of GTP hydrolysis and dissociation together was mea-
sured using Tem1 bound to γ-[
32P]GTP, whereas the rate of 
GTP dissociation alone was measured using Tem1 bound to the 
nonhydrolyzable GTP analogue γ-[
35S]GTP. As reported previ-
ously (Geymonat et al., 2002), Tem1 showed on its own GTPase 
activity and, to a lower extent, GTP release (compare Fig. 5 A 
with Fig. S3, available at http://www.jcb.org/cgi/  content/full/
jcb.200507162/DC1). The presence of Bfa1 stabilized Tem1 in 
the GTP-bound form, whereas Bub2 had little or no effect on 
its own (Fig. 5 A and Fig. S3). As previously shown (Geymonat 
et  al., 2002), Bub2 stimulated Tem1 GTPase activity in the 
presence of Bfa1 (Fig. 5 A) but not GTP dissociation (Fig. S3).
We then compared the GAP activity of purifi  ed GST-Bub2, 
GST-Bub2-HA3, and GST-Bub2-myc9. Surprisingly, Bub2-
myc9 could not stimulate the GAP activity of GTP-bound Tem1, 
whereas Bub2-HA3 was as active as untagged Bub2 (Fig. 5 B). 
Assaying the GTPase activity of Tem1 in the presence of Bfa1 
and increasing amounts of Bub2 or Bub2-myc9 confi  rmed that 
Bub2-myc9 is unable to stimulate Tem1 GTPase activity at 
any tested concentration (Fig. 5 C). These fi  ndings, along with 
the observation that Bub2-myc9 is profi  cient in activating the 
  spindle positioning checkpoint (Fraschini et al., 1999), argue 
that Bub2 GAP activity is dispensable for MEN inhibition.
However, the GAP activity of Bub2 might be required to 
control SPB localization of the Bub2–Bfa1 complex. To inves-
tigate this possibility, we generated a mutant Bub2 variant, 
  Bub2R85A, where an alanine residue replaces arginine 85, 
which appears to be the catalytic arginine in the GAP domain 
according to sequence comparison with other GAPs (Neuwald, 
1997; Albert et al., 1999). As shown in Fig. 5 (C and D), the 
R85A substitution completely abolished the in vitro GAP activ-
ity of both untagged and HA-tagged Bub2, whereas it could not 
further affect the already impaired activity of Bub2-myc9.
We then replaced the endogenous BUB2 gene with the 
  bub2R85A-HA3 allele in a haploid yeast strain and analyzed the 
localization of the corresponding protein by in situ immuno-
fluorescence. Unlike Bub2-HA3 and similar to Bub2-myc9, 
Bub2R85A-HA3 remained on both SPBs after the onset of ana-
phase in 75% of the cells (Fig. 5 E), indicating that Bub2 GAP 
activity is required to promote Bub2 release from the mother-
bound SPB at the metaphase–anaphase transition. Remarkably, 
the R85A substitution completely knocked out the checkpoint 
function of Bub2, Bub2-HA3, and Bub2-myc9. In fact, like 
bub2∆ cells, bub2R85A cells were hypersensitive to the micro-
tubule  depolymerizing compound benomyl (Fig. S4 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200507162/DC1) and 
re- replicated their DNA in the presence of nocodazole (Fig. S4 C),
indicating that checkpoint response to spindle disruption is 
completely abolished. In addition, like bub2∆ cells, they were 
unable to activate the spindle position checkpoint, as judged by 
their ability to rebud in the presence of misoriented spindles (Fig. 
S4 B), caused by deletion of DYN1 (Yeh et al., 1995) and KAR9 
(Korinek et al., 2000; Lee et al., 2000). Therefore, because both 
the addition of the myc epitopes and the R85A substitution im-
pair Bub2 GAP activity, the checkpoint defects observed in the 
R85A mutants should involve some Bub2 features other than 
GAP. Interestingly, the R85A substitution did not affect either the 
interaction of Bub2-myc9 and -HA3 with Tem1-GFP (Fig. S4 D) 
or the ability of Bub2-myc9 to pull down Bfa1-HA6 and vice 
versa (Fig. 5 G). However, unlike Bub2-myc9, Bub2R85A-myc9 
Figure 3.  The mitotic exit delay of cdc5-2 BUB2-myc9 
cells depends on functional Bfa1. Strains with the indi-
cated genotypes (ySP3426, ySP3480, and ySP3481) 
were grown in –Met medium, arrested in G1 with α factor, 
and released at 25°C in the presence of Met. Cells were 
collected at the indicated time points for FACS analysis 
of DNA contents (top) and to measure kinetics of nuclear 
division and spindle elongation/breakdown (bottom) as 
described in Fig. 2 B.JCB • VOLUME 172 • NUMBER 3 • 2006  340
failed to recruit Bfa1 at SPBs at any cell cycle stage (Fig. 5 F), 
in spite of its presence on both SPBs throughout the cell cycle 
(unpublished data), thus providing an explanation for its inabil-
ity to engage the checkpoint. Altogether, our data suggest that 
Bub2 GAP activity is not directly involved in Tem1 inactivation 
but is rather required to regulate Bub2 and Bfa1 asymmetrical 
localization at anaphase.
Factors that regulate the disappearance 
of Bub2 from the mother-bound SPB
To gain insights into the mechanisms that regulate Bub2/Bfa1 
disappearance from the mother-bound SPB at the onset of ana-
phase and their connections with mitotic exit control, we ana-
lyzed the distribution of Bub2-HA3 in different mutants. 
Because both interaction of cytoplasmic microtubules with the 
bud cortex (Adames et al., 2001; Pereira et al., 2001) and pas-
sage of the daughter-oriented SPB through the bud neck (Molk 
et al., 2004) have been proposed to signal mitotic exit, we 
  selected mutants on the basis of their possible defects in the 
  following processes: bud neck formation/localization, SPB reg-
ulation/localization, microtubule dynamics, and MEN activa-
tion. Because some of the analyzed mutations affect spindle 
positioning and therefore cause Bub2-HA3 to be maintained on 
both SPBs, the percentage of asymmetric versus symmetric 
Bub2-HA3 localization was scored only in cells undergoing 
properly oriented anaphase, as determined by DAPI staining of 
nuclei. The asymmetric localization of Bub2-HA3 was not dis-
rupted by mutations in genes encoding the following proteins 
(unpublished data): β-tubulin (tub2-104); the kinesins Cin8 and 
Kip3 (cin8∆ and kip3∆); the SPB components Cnm67 and 
Spc72 (cnm67∆ and spc72-7); the bud cortical proteins Kar9, 
Gic1, and Gic2 (kar9∆ and gic1∆ gic2∆); the MEN compo-
nents Cdc5 and -14; and the B-type cyclins Clb3 and -4, which 
have been shown to be localized asymmetrically on SPBs 
  (Liakopoulos et al., 2003). Conversely, lack of the plus-end 
  microtubule binding protein Bim1 increased the fraction of 
  anaphase cells with Bub2-HA3 on both SPBs from 10 to 25% 
(Fig. 6 A), suggesting that Bim1 contributes to the signal disap-
pearance of Bub2 from the mother-bound SPB in anaphase. 
Strikingly, we found that protein kinases localized at the bud 
neck, namely Swe1, Gin4, and Hsl1, participate in promoting 
Bub2-HA3 disappearance from the mother-bound SPB. In fact, 
the fraction of anaphase cells with symmetrically localized 
Bub2-HA3 increased from 10 to 43, 18, and 28% in swe1∆, 
gin4∆, and hsl1∆ mutants, respectively (Fig. 6 A). Deletion of 
SWE1 further increased the percentage of gin4∆ and hsl1∆ cells 
with Bub2-HA3 on both SPBs (Fig. 6 A), pointing to Swe1 as 
an important determinant for Bub2 asymmetry during anaphase. 
Consistent with a role for the bud neck in regulating Bub2/
Bfa1 localization, Swe1-lacking cells where the septin 
ring was disrupted by either the cdc12-1 septin mutation or 
overexpression of the dominant-negative CLA4t allele (Chiroli 
et al., 2003) led to symmetric localization of Bub2-HA3 at SPBs 
in 64 and 70% of anaphase cells, respectively. This result can be 
partly explained by the failure of these mutants to properly acti-
vate or localize at the bud neck the kinases Gin4, Hsl1, and 
Swe1, whose recruitment to the bud neck depends on septins 
(Carroll et al., 1998; Barral et al., 1999; Longtine et al., 2000). 
Therefore, bud neck components are necessary to signal Bub2 
elimination from the mother cell SPB when the spindle is prop-
erly oriented. To assess the effects of Bub2 retention at both 
SPBs on mitotic exit, we analyzed kinetics of spindle disassem-
bly in swe1∆ cells overexpressing CLA4t. As shown in Fig. 6 B, 
spindle disassembly, and therefore mitotic exit, was markedly 
delayed in these cells compared with wild type. It should be 
noted that, by 5 h, spindles had been correctly oriented in virtu-
ally all anaphase cells, suggesting that the lack of spindle disas-
sembly in  50% of the cells was not attributable to spindle 
misorientation but rather to the persistence of Bub2 on 
both SPBs because it was abolished by BUB2 deletion.
Similar to what we found with Bub2-myc9, both expres-
sion of CLA4t and the cdc12-1 mutation caused growth defects 
in cdc5-2 cells at the permissive temperature, and these syn-
thetic effects could be rescued by deleting BUB2 or BFA1 
Figure 4.  Hyperactivation of the MEN  restores 
viability of BUB2-myc9 cdc5-2 cells. Serial dilu-
tions of wild-type (ySP41), MET3-CDC5 cdc5-2 
(ySP3426),  MET3-CDC5 cdc5-2 BUB2-myc9 
(ySP3442 and ySP3480), MET3-CDC5 cdc5-2 
BUB2-myc9 GAL1-LTE1 (ySP3482 and 
ySP3495),  MET3-CDC5 cdc5-2 BUB2-myc9 
GAL1-TEM1 (ySP3646), MET3-CDC5 cdc5-2 
BUB2-myc9 GALs-TEM1 (ySP3904), MET3-
CDC5 cdc5-2 BUB2-myc9 carrying a TEM1-
bearing centromeric plasmid (YCp-TEM1), and 
MET3-CDC5 cdc5-2 BUB2-myc9 CDC14
TAB6-1 
(ySP3891) strains, grown in –Met medium 
(MET3-CDC5 on), were spotted on –Met, YEPD 
+Met (MET3 and GAL1/GALs promoters off), 
and YEPRG +Met (MET3-CDC5 off, GAL1/
GALs promoter on) plates, which were incu-
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(Fig. 6, C and D), further supporting the notion that symmetri-
cally localized Bub2 is deleterious for mitotic exit when Cdc5 is 
not fully functional.
Discussion
Disappearance of Bub2/Bfa1 from 
the mother-bound SPB as a trigger 
for mitotic exit
Eukaryotic cells that divide asymmetrically must prevent mi-
totic exit and cytokinesis when the spindle is misoriented 
with respect to the cell division axis. This represents a major 
issue for budding yeast, where assembly of the bud neck at 
the G1–S   transition defi  nes the site of cell division, compared 
with other organisms that establish the cleavage plane only 
after bipolar spindle formation. Therefore, it is not surprising 
that the GTPase Tem1 is fi  nely regulated, as it triggers mitotic 
exit and cytokinesis in budding yeast through MEN activation. 
Tem1 is kept inactive throughout most of the cell cycle by the 
Bub2–Bfa1 complex, which normally localizes with Tem1 at 
the bud-  directed spindle pole from the anaphase onset to the 
end of mitosis. Regulation of the MEN on the mother-bound 
Figure 5.  Lack of Bub2 GAP activity leads to persistent symmetric localization of Bub2 on SPBs. (A, B, and D) Bacterially expressed GST-Bub2, MBP-Bfa1, 
and 6×His-Tem1 were used in in vitro GAP assays as previously described (Geymonat et al., 2002). In brief, 240 nM of 6×His-Tem1 was loaded with 
γ-[
32P]GTP in either the absence or presence of 150 nM MBP-Bfa1 and incubated at 30°C for 10 min. The mixture was then added to 15 μM of GST-Bub2 
or buffer alone, and kinetics of GTP hydrolysis and dissociation was followed by ﬁ  lter binding assays (see Materials and methods). (C) Increasing amounts 
of the indicated Bub2 variants (0:1, 1:1, 2:1, 2.6:1, 6.6:1, 13:1, 26:1, 53:1, and 80:1 molar ratio Bub2/Bfa1) were added to 605 nM of 6×His-Tem1–
γ-[
32P]GTP in the presence of 378 nM MBP-Bfa1 (ﬁ  nal concentrations), and the fraction of ﬁ  lter-bound radioactivity was measured after 8 min. (E) Localiza-
tion of Bub2R85A-HA3 at anaphase SPBs was monitored by in situ immunostaining with anti-HA antibodies. (F) Localization of Bfa1-HA6 in asynchronous 
BUB2R85A-myc9 cells was monitored as in E. (G, top) Protein extracts from BUB2-myc9 (ySP710), bub2R85A-myc9 (ySP4696), BUB2-myc9 BFA1-HA6 
(ySP5087), and two different bub2R85A-myc9 BFA1-HA6 strains (ySP5118 and ySP5119) were used for Western blot analysis of either the total levels of 
Bub2-myc9 and Bfa1-HA6 (total) or the amount of Bub2-myc9 coimmunoprecipitating with Bfa1-HA6 (anti-HA IP). (bottom) Protein extracts from BFA1-HA6 
(ySP2035), BUB2-myc9 BFA1-HA6 (ySP5087), and two different bub2R85A-myc9 BFA1-HA6 strains (ySP5118 and ySP5119) were used for Western blot 
analysis of either the total levels of Bub2-myc9 and Bfa1-HA6 (total) or the amount of Bfa1-HA6 coimmunoprecipitating with Bub2-myc9 (anti-myc IP).JCB • VOLUME 172 • NUMBER 3 • 2006  342
SPB might have an important role in controlling mitotic exit 
because activation of the spindle position checkpoint, which 
prevents mitotic exit, preserves symmetric Bub2/Bfa1 local-
ization at SPBs (Pereira et al., 2001; Molk et al., 2004). On 
the other hand, unlike Bub2/Bfa1, Tem1 is also found on the 
mother-bound SPB when anaphase takes place properly (Molk 
et al., 2004).
Our characterization of the gain-of-function BUB2-myc9 
allele that allows localization of Bub2/Bfa1 on both SPBs 
throughout the cell cycle provides new evidence that Bub2/
Bfa1 removal from the spindle pole staying in the mother cell 
contributes to triggering mitotic exit. The role of Bub2/Bfa1 
disappearance from the mother-bound SPB in mitotic exit 
seems to overlap with other ways of activating Tem1, as it 
  becomes apparent only when Tem1 itself or the scaffold spin-
dle pole component Nud1 or the polo kinase Cdc5 function are 
crippled. In addition, we found that Bub2-myc9 is also lethal 
to cells overexpressing DMA2 (unpublished data), which we 
 recently revealed to be involved in Tem1 inactivation (Fraschini 
et al., 2004).
Nud1 activates the MEN by recruiting Tem1 and other MEN 
components to SPBs (Gruneberg et al., 2000), whereas Cdc5 trig-
gers mitotic exit through different mechanisms (for   review see 
Stegmeier and Amon, 2004). On the other hand, the observation 
that temperature sensitivity of the cdc5-1 and -2 mutants used in 
this study can be partially rescued by deletion of BFA1 (Hu et al., 
2001) suggests that they are impaired in Tem1 activation. Consis-
tently, higher TEM1 dosage suppresses cdc5-2 BUB2-myc9 lethal-
ity, indicating that the latter is likely attributable to either Tem1 
sequestration or a failure to properly activate it.
Although direct inhibitory phosphorylation seems to be 
a major function of Cdc5 in promoting mitotic exit, a mutant 
Figure 6.  Disappearance of Bub2 from the mother-
bound SPB depends on proteins localized at the bud neck. 
(A) Localization of Bub2-HA3 was analyzed on 
  formaldehyde-ﬁ   xed cells undergoing properly oriented 
anaphase (as assessed by DAPI staining) from logarithmi-
cally growing cultures at 25°C, with the exception of 
BUB2-HA3 4 ×  GAL1-CLA4t swe1∆ cells, which were 
grown in rafﬁ  nose-containing medium, arrested in G1 by 
α factor, and released in the presence of galactose for 
3 h to induce GAL1-CLA4t expression. At least 150 ana-
phase cells were scored for each strain. (B) Wild-type 
(ySP41), 4×  GAL1-CLA4t swe1∆ (ySP2711), and 4× 
GAL1-CLA4t swe1∆ bub2∆ (ySP2728) cells were grown 
in YEPR at 25°C, arrested in G1 with α factor, and re-
leased in YEPRG at 25°C. Galactose was added 30 min 
before the release. 120 min after the release, 10 μg/ml 
α factor was readded to prevent cells from entering a sec-
ond cell cycle. Cells were collected at the indicated times 
for kinetics of budding, nuclear division, and bipolar 
spindle formation/breakdown after in situ immunostain-
ing of tubulin. Bipolar spindles include both metaphase 
and anaphase spindles. (C) Serial dilutions of wild-type 
(ySP41),  cdc5-2 (ySP324), GAL1-CLA4t (ySP2622), 
GAL1-CLA4t cdc5-2 (ySP3565), GAL1-CLA4t cdc5-2 
bub2∆ (ySP4802), and GAL1-CLA4t cdc5-2 bfa1∆ 
(ySP4804) cell cultures were spotted on either YPD (GAL1 
promoter off) or YPRG (GAL1 promoter on) plates and in-
cubated at 25°C for 3 d. (D) Serial dilutions of wild type 
(ySP41),  cdc5-2 (ySP324), cdc12-1 (ySP293), cdc5-2 
bfa1∆ (ySP3671), cdc12-1 cdc5-2 (ySP4473 and 
ySP4474), and cdc12-1 cdc5-2 bfa1∆ (ySP4518 and 
ySP4519) were spotted on YPD plates, which were incu-
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  version of Bfa1 no longer phosphorylatable by Cdc5 (Bfa1-
11A; Hu et al., 2001) was not synthetically lethal with Bub2-
myc9 (Table I), indicating that Cdc5 likely regulates Bfa1 
function by additional means besides direct phosphorylation. 
Another task that Cdc5 might carry out to promote mitotic exit 
is phosphorylation of the Tem1 activator Lte1 (Lee et al., 2001). 
However, LTE1 deletion does not cause synthetic effects when 
combined with the BUB2-myc9 allele (Table I). Therefore, Cdc5 
might contribute to MEN activation and/or Bub2/Bfa1 inhibi-
tion through redundant mechanisms. One of them is likely 
  related to the involvement of Cdc5 in the FEAR pathway 
 (Stegmeier et al., 2002; Yoshida et al., 2002). Accordingly, when 
we inactivated the latter by the esp1-1 separase mutant allele, 
Bub2-myc9 prevented mitotic exit (Fig. S2).
Coupling between mitotic exit and nuclear partitioning 
has been proposed to be triggered by exposure of Tem1, carried 
by the daughter-oriented SPB, to Lte1, which is constrained 
in the bud (Bardin et al., 2000; Bloecher et al., 2000; Pereira 
et al., 2000). Although this mechanism might be important for 
Tem1 activation in late anaphase at low temperatures, our data 
suggest that it might not be suffi  cient to drive mitotic exit when 
Bub2/Bfa1 remains symmetrically localized on SPBs. In fact, 
mitotic exit and entry into a new round of DNA replication do 
not take place in esp1-1 mutant cells when Bub2/Bfa1 is present 
on both SPBs, in spite of the encounter between Tem1 and Lte1. 
Accordingly, Lte1 was found to be dispensable for the unsched-
uled mitotic exit of mutants defective in the spindle position 
checkpoint (Adames et al., 2001). We therefore propose that 
disappearance of Bub2/Bfa1 from the mother-bound SPB con-
tributes to couple mitotic exit with properly oriented chromo-
some partitioning. Interestingly, a role for the mother cell in 
controlling the MEN has recently been highlighted by the fi  nd-
ing that the Kin4 kinase, involved in the spindle position check-
point, is specifi  cally localized in the mother cell (D’Aquino 
et al., 2005; Pereira and Schiebel, 2005).
A novel view for Bub2’s role in controlling 
mitotic exit
The Bub2–Bfa1 complex is proposed to prevent mitotic exit by 
stimulating Tem1 GTPase activity both in budding and in fi  ssion 
yeast (Simanis, 2003; for review see Stegmeier and Amon, 2004). 
According to this hypothesis, knocking down the GAP activity of 
the complex should allow Tem1 activation even in conditions 
triggering a checkpoint response, i.e., microtubule defects or 
spindle misorientation. Because Bub2 but not Bfa1 carries a con-
served GAP domain, we directly tested this hypothesis by substi-
tuting the putative catalytic arginine (R85) with alanine (Neuwald, 
1997; Albert et al., 1999). Indeed, unlike wild-type Bub2, 
  Bub2R85A completely lacked in vitro GAP activity and caused 
checkpoint defects similar to BUB2 deletion. Surprisingly, we 
also found that Bub2-myc9 had no detectable in vitro GAP activ-
ity, although it could normally support the checkpoint, suggesting 
that Bub2 likely contributes to Tem1 inhibition by means other 
than stimulating its GTPase activity. It is important to emphasize 
that we and others (Geymonat et al., 2002) have shown that Tem1 
on its own has a high rate of GTP hydrolysis, as well as guanosine 
5′-diphosphate (GDP) release, unlike other Ras-like G proteins. 
In agreement with Tem1’s ability to switch by itself between 
GTP- and GDP-bound forms, Lte1 mitotic exit function does not 
seem to be related to its   putative guanine nucleotide exchange 
factor activity on Tem1   (Yoshida et al., 2003). Rather, it could be 
linked to its ability to stimulate Tem1 recruitment to the daughter-
directed SPB after anaphase (Molk et al., 2004).
Thus, among several possible models, we favor the idea 
that Bfa1 alone is responsible for Tem1 inhibition in BUB2-myc9 
cells (Fig. 7 A). Indeed, Bfa1 has been shown to be able to inhibit 
Tem1 and mitotic exit independently of Bub2 (Li, 1999; Ro 
et al., 2002), perhaps by preventing its cycling between GTP and 
GDP binding (Geymonat et al., 2002) and/or by inhibiting its 
binding to Cdc15 (Ro et al., 2002). If Bfa1 alone can account for 
Tem1 inhibition in BUB2-myc9 cells, the different abilities of 
Bub2R85A and Bub2-myc9 in activating the spindle position 
checkpoint could be explained by their different abilities to 
  recruit Bfa1 at SPBs. In fact, whereas Bub2-myc9 is more effec-
tive than wild-type Bub2 at keeping Bfa1 at both SPBs during 
anaphase, Bub2R85A fails to bring Bfa1 to either SPB through-
out the cell cycle. Of course, such a model does not rule out the 
possibility that Bub2 GAP activity helps inhibit Tem1 upon 
checkpoint response in wild-type cells. In any case, our data in-
dicate that Bub2 GAP activity promotes the disappearance of the 
Bub2–Bfa1 complex from the mother-bound SPB at the   onset of 
anaphase (Fig. 7 B) because both Bub2R85A and Bub2-myc9 
Figure 7.  A schematic model for mitotic exit. In the presence of spindle positioning defects (A), Bub2-dependent Bfa1 retention at both SPBs prevents 
  mitotic exit by inhibiting Tem1. When anaphase takes place correctly and one SPB crosses the bud neck (B), a signal is sent to the mother-bound SPB, where 
the Bub2–Bfa1 complex is removed through the action of Bub2 GAP activity, thus leading to Tem1 activation at this pole. This helps trigger mitotic exit, 
  together with Bfa1 inhibition by Cdc5, presumably at the bud-directed SPB, and with increased Tem1 loading on the same SPB.JCB • VOLUME 172 • NUMBER 3 • 2006  344
are maintained on both SPBs from S phase to   telophase. Upon 
spindle position checkpoint activation, Bub2 would be required 
to maintain Bfa1 at SPBs (Fig. 7 A), whereas its GAP activity 
could render the system more dynamic and help release Tem1 
from Bfa1, along with Cdc5-dependent Bfa1 phosphorylation. 
Lte1-dependent recruitment of Tem1 on the bud-directed SPB 
after anaphase would also contribute to MEN activation (Fig. 7 B). 
Whether the in vivo target of Bub2 GAP activity in promoting its 
own disappearance from the mother-bound SPB is Tem1 or other 
proteins remains to be   established. One possibility is that bud 
neck G proteins get   exposed to Bub2 only when the daughter-
  directed SPB crosses the bud neck, thus signaling Bub2/Bfa1 
disappearance from the mother-bound SPB. The fi  nding that bud 
neck components are required for Bub2 asymmetric localization 
at SPBs (see the   following paragraph) supports this hypothesis.
Signaling mitotic exit through the transit 
of one SPB through the bud neck
Inappropriate mitotic exit of spindle positioning–defective mu-
tants often correlates with interaction of the spindle with the 
bud neck (Adames et al., 2001). In addition, during the unper-
turbed cell cycle, mitotic exit is tightly linked to the passage of 
one SPB through the bud neck (Molk et al., 2004). Our data 
clearly indicate a relationship between Bub2/Bfa1 disappear-
ance from the mother-bound SPB and the function of bud neck 
components (i.e., PAK kinases; septins; and the protein kinases 
Hsl1, Gin4, and Swe1), thus providing a molecular basis for the 
aforementioned results. In fact, impairment of bud neck kinases 
allows Bub2, and presumably its partner Bfa1, to persist on both 
SPBs even when the spindle is properly oriented during anaphase. 
Localization of bud neck components takes place in a hierarchi-
cal manner, with PAK kinases contributing to assembly of the 
septin ring (Cvrckova et al., 1995), which is in turn essential for 
recruiting Gin4 and Hsl1 to the bud neck (Barral et al., 1999; 
Longtine et al., 2000), where they are required for Swe1 local-
ization (Longtine et al., 2000). This suggests that Swe1 might 
promote Bub2/Bfa1 disappearance from the mother-bound SPB 
more directly than upstream components. However, other bud 
neck components beside Swe1 are likely implicated in this pro-
cess because the fraction of anaphase swe1∆ cells with sym-
metrically localized Bub2 further increases upon septin ring 
disruption by a cdc12 mutation or CLA4t overexpression. We 
therefore propose that passage of the daughter-directed SPB 
through the bud neck signals the removal of Bub2/Bfa1 from 
the mother-bound SPB, thus setting Tem1 free of inhibition at 
this spindle pole. This, together with the Lte1-mediated recruit-
ment of additional Tem1 at the daughter-directed SPB and the 
Cdc5-dependent inhibition of Bfa1, perhaps taking place at the 
same SPB, would trigger mitotic exit (Fig. 7 B). How the signal 
is transmitted from the SPB passing through the bud neck to the 
mother-bound SPB is unclear at the moment, but the plus-end 
microtubule binding protein Bim1 might be implicated in the 
signaling, as its lack partially disrupts the asymmetric localiza-
tion of Bub2. Uncovering the molecular details of this process 
will be an important challenge for the future and will shed light 
on the mechanisms coupling mitotic exit and spindle position-
ing in yeast as well as in other eukaryotic organisms.
Materials and methods
Strains, media, and reagents
All yeast strains (Table S1, available at http://www.jcb.org/cgi/content/
full/jcb.200507162/DC1) were derivatives of or were backcrossed at 
least three times to W303 (ade2-1, trp1-1, leu2-3,112, his3-11,15, ura3, 
and ssd1). Cells were grown in YEP medium (1% yeast extract, 2% bacto-
peptone, and 50 mg/l adenine) supplemented with 2% glucose (YEPD), 
2% rafﬁ  nose (YEPR), or 2% rafﬁ  nose and 1% galactose (YEPRG). Unless 
otherwise stated, α factor, nocodazole, and benomyl were used at 2, 15, 
and 12.5 μg/ml, respectively. Synchronization experiments were per-
formed at 25°C. For galactose induction of synchronized cells, galactose 
was added half an hour before release from α factor. MET3-CDC5 cells 
were grown in synthetic medium lacking Met, whereas shutoff of the MET3 
promoter was done by resuspending cells in YEPD medium supplemented 
with 2 mM Met. Bacterial cells were grown in LD broth (1% bactotryptone, 
0.5% yeast extract, and 0.5% NaCl, pH 7.25) supplemented with 50 μg/ml 
ampicillin and 34 μg/ml chloramphenicol.
Plasmid constructions and genetic manipulations
Standard techniques were used for genetic manipulations (Sherman, 1991; 
Maniatis et al., 1992). To generate the MET3-CDC5 plasmid (pSP82), a 
NdeI–XhoI PCR fragment containing CDC5 open reading frame was 
cloned in the NdeI–XhoI sites of a pRS305 vector carrying the MET3 pro-
moter (pSP81). pSP82 integration was directed at the LEU2 locus by EcoRI 
digestion. Single integration of the plasmid was assessed by Southern 
analysis. To clone BUB2 under the GAL1-10 promoter (plasmid pSP67) an 
HpaI–SphI PCR product containing the BUB2 coding region was cloned 
into [BamHI]–SphI of a GAL1-10–bearing YIplac211 vector. pSP67 inte-
gration was directed to the URA3 locus by StuI digestion. The copy number 
of the integrated plasmid was veriﬁ  ed by Southern analysis. To clone TEM1 
under the GALs promoter (plasmid pSP233), a BamHI–SalI PCR product 
was ligated into BamHI–SalI of a GALs-bearing YCp vector (Mumberg 
et al., 1994). To generate a TEM1-containing YCp vector (pSP237), a 
SmaI PCR fragment bearing the TEM1 coding region was ligated into SmaI 
of pFL39. To generate HA-tagged alleles, BUB2, BFA1, and TEM1 were 
tagged immediately before the stop codon by one-step gene tagging (Knop 
et al., 1999). The TEM1-GFP pRS315 plasmid (Pereira et al., 2002) was 
a gift from E. Schiebel (Center for Molecular Biology Heidelberg, Heidelberg, 
Germany). The bub2R85A allele was produced by site-directed mutagene-
sis (QuikChange site-directed mutagenesis kit; Stratagene) on pSP279, a 
YIplac211 vector carrying 355 bp of 5′ noncoding and 663 bp of coding 
region of BUB2. Integration of the mutagenized plasmid (pSP285) was di-
rected to the BUB2 locus by BamHI digestion, thus generating a full-length 
mutant allele plus a truncated gene. Copy number of the integrated plas-
mid was veriﬁ  ed by Southern analysis. To express BUB2 in Escherichia 
coli, wild-type or R85A mutant BUB2, either untagged or tagged with three 
HA or nine myc epitopes, were ampliﬁ  ed by PCR from genomic DNA and 
subcloned in the EcoRI site of pGEX6P-2rbs (a gift from A. Musacchioi, 
  Instituto Europeo di Oncologia, Milan, Italy) to generate pSP359 (GST-
  bub2R85A), pSP295 (GST-bub2R85A-HA3), pSP296 (GST-BUB2-HA3), 
pSP358 (GST-BUB2), pSP304 (GST-bub2R85A-myc9), and pSP312 (GST-
BUB2-myc9). A BamHI–PstI PCR fragment containing the TEM1 open read-
ing frame was cloned into BamHI–PstI of pPROEX HTa (Invitrogen) to 
generate pSP276. The MBP-BFA1 construct (Pereira et al., 2002) was a gift 
from M. Geymonat (National Institute for Medical Research, London, UK).
Protein expression and puriﬁ  cation
E. coli BL21 carrying pLysE plasmid (Novagen) and TEM1-6×His, MBP-
BFA1, GST, GST-BUB2, GST-BUB2-HA3, GST-BUB2-myc9, GST-bub2R86A, 
GST-bub2R86A-HA3, and GST-bub2R86A-myc9 expression plasmids were 
grown in LD broth containing ampicillin and chloramphenicol at 37°C for 
3 h, transferred to 14°C for 1 h, and induced with 0.1 mM isopropyl-1-thio-
β-D-galactopyranoside for 15 h. Cells expressing MBP-Bfa1, Tem1-6×His, 
and different GST-Bub2 fusion proteins were resuspended, respectively, in 
the following cold lysis buffers: 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 
2 mM DTT, and 1 mM 4-(2-Aminoethyl)-bezenesulfonylﬂ   uoride; 50 mM 
Tris-HCl, pH 8.0, 300 mM NaCl, 2 mM MgCl2, and 10 mM imidazole 
supplemented with a cocktail of protease inhibitors (Complete; Boeh-
ringer); and 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, and 2 mM DTT 
  supplemented with a cocktail of protease inhibitors. Cells were incubated 
with 1 mg/ml lysozyme in ice for 30 min, placed at 37°C for 5 min, and 
sonicated at 4°C. The extract was then clariﬁ   ed by centrifugation at 
15,000 rpm for 30 min at 4°C. Tem1-6×His fusion protein was puriﬁ  ed by BUB2 LOCALIZATION AND MITOTIC EXIT CONTROL • FRASCHINI ET AL. 345
afﬁ  nity chromatography with Ni-NTA columns (QIAGEN). The MBP-Bfa1 
fusion protein was puriﬁ  ed using amylose resin (New England Biolabs, 
Inc.), whereas the different GST-Bub2 fusion proteins were puriﬁ  ed with 
glutathione-Sepharose (GE Healthcare). After elution, the fusion proteins 
were dialyzed against 50 mM Tris-HCl, pH 7.5, and 200 mM NaCl and 
stored at –80°C. For quantiﬁ  cation, puriﬁ  ed proteins were analyzed by 
Coomassie staining and by Western blot with anti-GST polyclonal anti-
bodies (Santa Cruz Biotechnology, Inc.), anti-MBP Mab antibodies (New 
England Biolabs, Inc.), and 6×His Mab (CLONTECH Laboratories, Inc.).
GTPase assays
GTPase assays were performed according to Geymonat et al. (2002). In 
brief, 1 μg of Tem1-6×His was incubated in 25 μl of loading buffer (20 mM 
Tris-HCl, pH 7.5, 25 mM NaCl, 5 mM MgCl2, and 0.1 mM DTT) contain-
ing 0.1 MBq of γ-[
32P]GTP or 0.03 MBq of γ-[
35S]GTP in the absence or 
presence of MBP-Bfa1 for 10 min at 30°C. The reaction was then put on 
ice, and 10 μl of reaction were added to 50 μl of reaction buffer (20 mM 
Tris-HCl, pH 7.5, 2 mM GTP, and 0.6 μg/μl BSA) containing GST-Bub2. 
The mixture was incubated at 30°C, and for each time point 10 μl of the 
reaction was diluted in 990 μl of cold washing buffer (20 mM Tris-HCl, 
pH 7.5, 50 mM NaCl, and 5 mM MgCl2). The samples were ﬁ  ltered 
through nitrocellulose ﬁ  lters, washed with 12 ml of cold washing buffer, 
and air dried, and the ﬁ  lter-bound radioactivity nucleotide was determined 
by scintillation counting. Each assay was repeated at least two times, and 
reproducible results were obtained.
Immunoprecipitations, Western blot analysis, and kinase assays
Immunoprecipitations were performed as described in Fraschini et al. 
(2001). Bub2-myc9 was immunoprecipitated from 1 mg of total extract by 
protein A–Sepharose beads cross-linked to anti-myc antibodies. Bub2-HA3 
and Bfa1-HA6 were immunoprecipitated from 1 mg of total extract by 
  protein A–Sepharose beads cross-linked to anti-HA antibodies. For West-
ern blot analysis, protein extracts were prepared according to Surana 
et  al. (1993). Proteins transferred to Protran membranes (Schleicher & 
Schuell) were probed with 9E10 mAb for myc-tagged Bub2, with 12CA5 
mAb for HA-tagged Bub2 and Bfa1, and with polyclonal antibodies 
against GFP for GFP-tagged Tem1 (Invitrogen), Swi6, Clb2, and Sic1. Sec-
ondary antibodies were purchased from GE Healthcare, and proteins 
were detected by an enhanced chemiluminescence system according to 
the manufacturer. Histone H1 kinase activity was measured as previously 
described (Surana et al., 1993).
Other techniques
Flow cytometric DNA quantitation was determined according to Fraschini 
et al. (1999) on a FACScan (Becton Dickinson). In situ immunoﬂ  uorescence 
was performed according to Fraschini et al. (1999). Immunostaining of 
α-tubulin was performed with the YOL34 monoclonal antibody (Serotec) 
followed by indirect immunoﬂ   uorescence using rhodamine-conjugated 
anti–rat antibody (1:100; Pierce Chemical Co.). Immunostaining of myc-
tagged proteins was done with the 9E10 mAb, whereas that of HA-tagged 
proteins was done with the 16B12 mAb (Babco), followed by indirect 
  immunoﬂ   uorescence using CY3-conjugated goat anti–mouse antibody 
(1:1,000; GE Healthcare). Cytokinesis defects were assessed upon cell 
wall digestion with zymolase. Digital images were acquired on a ﬂ  uores-
cent microscope (Eclipse E600; Nikon) equipped with a charge-coupled 
device camera (DC350F; Leica) at 20°C with an oil 100× 1.3 NA Plan-
Fluor   objective (Nikon), using FW4000 software (Leica).
Online supplemental material
Fig. S1 shows that overexpression of BUB2 in cdc5-2 cells causes effects 
similar to Bub2-myc9. Fig. S2 shows that symmetrically localized Bub2 
prevents exit from mitosis in esp1-1 cells. Fig. S3 demonstrates that Bub2 
does not stimulate GTP dissociation from Tem1. Fig. S4 shows that the 
GAP-defective  bub2R85A mutant fails to activate the spindle position 
checkpoint. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200507162/DC1.
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